Similar articles for PMID: 17915314

Year	Number of Results
1951	3
1952	1
1954	1
1955	2
1960	2
1963	1
1968	1
1972	1
1975	1
1976	1
1978	1
1980	1
1981	1
1983	1
1984	1
1987	1
1988	1
1991	1
1993	1
1994	1
1996	1
1998	2
2004	1
2005	1
2006	2
2007	7
2008	12
2009	7
2016	1
2019	1
2024	0

1

Have myeloma cells osteoclast-like activity? Implications into the pathogenesis of myeloma bone disease.

Terpos E. Terpos E. Leuk Res. 2008 Apr;32(4):521-2. doi: 10.1016/j.leukres.2007.08.018. Epub 2007 Oct 3. Leuk Res. 2008. PMID: 17915314 No abstract available.

2

Myeloma and bone disease: "the dangerous tango".

Epstein J, Walker R. Epstein J, et al. Clin Adv Hematol Oncol. 2006 Apr;4(4):300-6. Clin Adv Hematol Oncol. 2006. PMID: 16728940 Review.

3

Bortezomib directly inhibits osteoclast function in multiple myeloma: implications into the management of myeloma bone disease.

Terpos E. Terpos E. Leuk Res. 2008 Nov;32(11):1646-7. doi: 10.1016/j.leukres.2008.06.017. Epub 2008 Jul 9. Leuk Res. 2008. PMID: 18614229 No abstract available.

4

Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.

Boissy P, Andersen TL, Lund T, Kupisiewicz K, Plesner T, Delaissé JM. Boissy P, et al. Leuk Res. 2008 Nov;32(11):1661-8. doi: 10.1016/j.leukres.2008.02.019. Epub 2008 Apr 18. Leuk Res. 2008. PMID: 18394701

5

Chemokines in multiple myeloma.

Aggarwal R, Ghobrial IM, Roodman GD. Aggarwal R, et al. Exp Hematol. 2006 Oct;34(10):1289-95. doi: 10.1016/j.exphem.2006.06.017. Exp Hematol. 2006. PMID: 16982321 Free PMC article. Review.

6

[Link between osteoclastogenesis, angiogenesis and myeloma expansion].

Abe M. Abe M. Clin Calcium. 2008 Apr;18(4):473-9. Clin Calcium. 2008. PMID: 18379029 Review. Japanese.

7

Pathophysiology of multiple myeloma bone disease.

Lentzsch S, Ehrlich LA, Roodman GD. Lentzsch S, et al. Hematol Oncol Clin North Am. 2007 Dec;21(6):1035-49, viii. doi: 10.1016/j.hoc.2007.08.009. Hematol Oncol Clin North Am. 2007. PMID: 17996587 Review.

8

Multiple myeloma presenting as cryoglobulinaemia.

Gordon-Smith EC, Harrison RJ, Hobbs JR. Gordon-Smith EC, et al. Proc R Soc Med. 1968 Nov;61(11 Part 1):1112-5. Proc R Soc Med. 1968. PMID: 5722545 Free PMC article. No abstract available.

9

A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma.

Sondergaard TE, Pedersen PT, Andersen TL, Søe K, Lund T, Ostergaard B, Garnero P, Delaisse JM, Plesner T. Sondergaard TE, et al. Hematol Oncol. 2009 Mar;27(1):17-22. doi: 10.1002/hon.869. Hematol Oncol. 2009. PMID: 18668701 Clinical Trial.

10

[Apparently isolated plasmacytoma of the nasal fossae; rapid progression to multiple myeloma].

Gaillard J, Haguenauer JP, Gignoux B, Romanet P. Gaillard J, et al. JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1975 Nov;24(9):727-8. JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1975. PMID: 128608 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

57 results

Results by year